Optiva eye drops 5 + 9mg/ml 10ml

Indications for use

Symptomatic treatment of dry eye syndrome.

Pharmacokinetics

Human pharmacokinetics studies have not been conducted.

Clinical Pharmacology

Carmellose sodium and glycerol have properties of a protector of the corneal epithelium, improve the moistening of the cornea with reduced secretion of tear fluid and increase the stability of the tear film.

Use during pregnancy and during breastfeeding

Strictly controlled studies in pregnant women and nursing mothers was not conducted.

In animal studies there was no adverse effect of the active ingredients of the drug. The optiv is not absorbed from the mucosal surface, thus, there are no objective prerequisites for the possible excretion of its components in breast milk.

Use of the drug during pregnancy and during lactation is possible with caution.

Contraindications

• Hypersensitivity to the drug.
• Children's age up to 18 years (experience of application is absent).

• Pregnancy.
• Breastfeeding period (due to limited data).

Side effect

• On the part of the organ of vision

  Often - conjunctival hyperemia, eyelid hyperemia, blurred vision, feeling of dryness of the eye, discomfort during instillation, itching and eye irritation, formation of crusts on the edge of the eyelid.

• In the post-marketing period, the following adverse reactions of the drug Optive were received (frequency unknown)

  Pain in the eye, appearance of discharge from the eye, foreign body sensation in the eye, eyelid edema, increased tearing, photophobia.

Overdose

Information about cases of drug overdose Optiv is absent.

Interaction

Data on drug interactions drug Optiv no.

When prescribing with other local ophthalmologic agents, the interval between instillation of the drug Optive and other eye drops should be at least 5 minutes in order to exclude the possibility of "washing out" of the drug.

Dosage and administration

The drug is instilled 1-2 drops in the conjunctival sac as needed.

Precautionary measures

The product is intended for topical use only.

It can not be used in violation of the integrity of the film covering the neck of the bottle, clouding of the container or changing its color.

Do not touch the pipette tip to any surface, including the conjunctiva, in order to avoid contamination of the vial contents.

It is necessary to close the bottle immediately after applying the drug.

Consult a doctor if you have pain in the eye area, blurred vision, prolonged hyperemia or irritation of the mucous membranes of the eyes. Also, seek advice if there is no improvement in the use of the drug and / or if you have other adverse effects that are increasing or not resolved within 72 hours.

• Impact on driving and performance of potentially hazardous activities

  If after instillation blurred vision is noted, it is necessary to refrain from driving and engaging in potentially hazardous activities that require increased concentration of attention and quickness of psychomotor reactions until it is restored.

Storage conditions

• Store in a dark place at a temperature not exceeding 25 ° C.